Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanbin Pang

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Frontiers in Oncology|September 10, 2025
Successful remission induction therapy with azacitidine and venetoclax for a treatment-naive elderly patient with ETP/myeloid mixed-phenotype acute leukemia: a case reportKaikai Huang, Yanbin Pang
Frontiers in Medicine|June 10, 2026
Rapid early hematological response in a newly diagnosed patient with very severe aplastic anemia: a case report of high-dose romiplostim, hetrombopag and IST combination therapyLiangkui Luo, Kaikai Huang, Yanbin Pang
ISA Transactions|July 22, 2006
Analysis of control interval for foundation fieldbus-based control systemsYanbin Pang, Shuang-Hua Yang, Hirokazu Nishitani
The Journal of International Medical Research|March 19, 2021
The role of Src homology region 2 domain-containing phosphatase-1 hypermethylation in the classification of patients with myelodysplastic syndromes and its association with signal transducer and activator of transcription 3 phosphorylation in skm-1 cellsYing Han, Jin Zhang, Yanbin Pang, et al.
The Journal of International Medical Research|May 13, 2022
The FLT3 Y842D mutation may be highly sensitive to midostaurin: a case reportShujiao He, Minjie Zhang, Jieying Li, et al.
Frontiers in Oncology|September 28, 2020
The (Neutrophils + Monocyte)/Lymphocyte Ratio Is an Independent Prognostic Factor for Progression-Free Survival in Newly Diagnosed Multiple Myeloma Patients Treated With BCD RegimenYanbin Pang, Hong Shao, Ziheng Yang, et al.
Oncology Letters|October 16, 2019
Phenotype of mesenchymal stem cells from patients with myelodyplastic syndrome maybe partly modulated by decitabineYanbin Pang, Suxia Geng, Hongyang Zhang, et al.
American Journal of Translational Research|August 15, 2017
Premature exhaustion of mesenchymal stromal cells from myelodysplastic syndrome patientsYanbin Pang, Chengxin Deng, Suxia Geng, et al.
Medicine|December 20, 2023
Favorable response of a patient with primary B/myeloid mixed phenotype acute Leukemia to CD19-CAR-T: Case report and literature reviewLixin Wang, Yanbin Pang, Chuling Fang, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Frontiers in Oncology|September 10, 2025
Successful remission induction therapy with azacitidine and venetoclax for a treatment-naive elderly patient with ETP/myeloid mixed-phenotype acute leukemia: a case reportKaikai Huang, Yanbin Pang
Frontiers in Medicine|June 10, 2026
Rapid early hematological response in a newly diagnosed patient with very severe aplastic anemia: a case report of high-dose romiplostim, hetrombopag and IST combination therapyLiangkui Luo, Kaikai Huang, Yanbin Pang
ISA Transactions|July 22, 2006
Analysis of control interval for foundation fieldbus-based control systemsYanbin Pang, Shuang-Hua Yang, Hirokazu Nishitani
The Journal of International Medical Research|March 19, 2021
The role of Src homology region 2 domain-containing phosphatase-1 hypermethylation in the classification of patients with myelodysplastic syndromes and its association with signal transducer and activator of transcription 3 phosphorylation in skm-1 cellsYing Han, Jin Zhang, Yanbin Pang, et al.
The Journal of International Medical Research|May 13, 2022
The FLT3 Y842D mutation may be highly sensitive to midostaurin: a case reportShujiao He, Minjie Zhang, Jieying Li, et al.
Frontiers in Oncology|September 28, 2020
The (Neutrophils + Monocyte)/Lymphocyte Ratio Is an Independent Prognostic Factor for Progression-Free Survival in Newly Diagnosed Multiple Myeloma Patients Treated With BCD RegimenYanbin Pang, Hong Shao, Ziheng Yang, et al.
Oncology Letters|October 16, 2019
Phenotype of mesenchymal stem cells from patients with myelodyplastic syndrome maybe partly modulated by decitabineYanbin Pang, Suxia Geng, Hongyang Zhang, et al.
American Journal of Translational Research|August 15, 2017
Premature exhaustion of mesenchymal stromal cells from myelodysplastic syndrome patientsYanbin Pang, Chengxin Deng, Suxia Geng, et al.
Medicine|December 20, 2023
Favorable response of a patient with primary B/myeloid mixed phenotype acute Leukemia to CD19-CAR-T: Case report and literature reviewLixin Wang, Yanbin Pang, Chuling Fang, et al.
Pageof 1